Micro-X Ltd. (AU:MX1)
ASX:MX1
MX1 Stock Chart & Stats
AU$0.10
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.10
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.12
Previous CloseN/A
Volume191.73K
Average Volume (3M)189.28K
Market Cap
AU$39.93M
Enterprise ValueAU$36.54M
Total Cash (Recent Filing)AU$4.90M
Total Debt (Recent Filing)AU$5.13M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding726,076,900
10 Day Avg. Volume131,613
30 Day Avg. Volume189,275
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)3.96
Price to Sales (P/S)2.29
P/FCF Ratio-3.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.16Price Target Upside60.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$28.16M
Bulls Say, Bears Say
Bulls Say
Proprietary CNT X-ray TechnologyMicro-X's proprietary carbon-nanotube cold-cathode X-ray source is a durable technological moat. It enables lightweight, portable diagnostic systems tailored to point-of-care and mobile settings, supporting product differentiation, higher adoption in niche markets, and licensing or OEM opportunities over time.
High Gross MarginsA sustained gross margin near 80% indicates strong unit economics for the core hardware and component sales. This margin provides structural capacity to fund R&D, service networks, and commercialization if operating expenses are controlled, supporting long-term scalability of profitable product lines.
Recurring Revenue PotentialRecurring revenue from consumables, service, and maintenance tied to installed systems creates durable, predictable revenue streams. Over time these annuity-like revenues increase lifetime customer value and smooth revenue volatility as device install base grows across hospitals and emergency services.
Bears Say
Declining RevenueA recent revenue decline of 9.5% signals demand or execution issues in commercialization. Persistent top-line contraction undermines scale economics and makes it harder to leverage high gross margins into profit; sustained declines could threaten market footholds and partner confidence.
Negative Cash FlowsNegative operating and free cash flows indicate ongoing cash burn from operations and investment. Over several quarters this erodes liquidity, forces reliance on financing, and constrains marketing, service expansion, or R&D investment necessary to convert innovative tech into durable commercial success.
Rising Leverage & Negative ROEHigher leverage (D/E ~0.87) combined with negative ROE raises financial risk: debt servicing limits flexibility and amplifies downside during revenue shortfalls. For a loss-making med-tech, increased reliance on debt can pressure cash runway and limit ability to invest in commercialization.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.04 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$39.93M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 147 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of -AU$0.006 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 726,076,900 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.01 in its last earnings report, missing expectations of -AU$0.006. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.16 (60.00% Upside)
AU$0.16 (60.00% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth AU$1.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.40%
12-Months-Change
Fundamentals
Return on Equity
-180.06%
Trailing 12-Months
Asset Growth
-12.76%
Trailing 12-Months
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, and manufactures lightweight carbon nano tube-based X-ray products for the healthcare and security imaging markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; Carestream DRX Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals; and IED X-ray cameras. It also provides miniature baggage scanners to detect hidden threats concealed within passenger carry-on luggage; airport screening reimagined, a passenger self-screening airport checkpoint; and brain CT scanners for use in road and air ambulances. The company was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.16
▲(60.00% Upside)
Technical Analysis
Cyclopharm Limited
―
CleanSpace Holdings Ltd.
―
EMvision Medical Devices Ltd.
―
Control Bionics Ltd.
―
4DMedical Ltd
―
Options Prices
Currently, No data available
---